Group 1 - Gannee Pharmaceutical (603087.SH) reported its Q3 2025 results, with 62 institutional investors holding a total of 80.31 million shares, representing 13.44% of the total share capital [1] - The top ten institutional investors collectively hold 11.13% of the shares, a decrease of 1.13 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 21 funds increased their holdings, accounting for a 0.67% increase, while 24 funds decreased their holdings, representing a 0.41% decrease [2] - Seven new public funds disclosed their holdings this period, while 384 funds did not disclose their holdings compared to the previous quarter [2] - In the insurance sector, one insurance company, China Life Insurance Co., Ltd., reduced its holdings slightly [2]

Group 1 - Tsinghua Dongbao (600867.SH) reported its Q3 2025 results, with 9 institutional investors holding a total of 928 million shares, representing 47.39% of the total share capital [1] - The institutional holding ratio increased by 0.77 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, namely the Innovative Medicine fund, increased its holdings slightly, while two funds, including the China Securities National Biomedicine Index A and Southern CSI 500 ETF, reduced their holdings by 0.17% [2] - A total of 249 public funds did not disclose their holdings this period, including Tianhong National Biomedicine ETF and Guotai CSI Biomedicine ETF [2] Group 3 - MACD golden cross signals have formed, indicating a positive trend for certain stocks [3]

Group 1 - Health元 (600380.SH) reported its Q3 2025 results, with 8 institutional investors holding a total of 1.022 billion shares, representing 55.89% of the total share capital [1] - The proportion of shares held by institutional investors decreased by 2.41 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one public fund, namely the innovative drug fund, increased its holdings slightly, while another fund, the Southern CSI 500 ETF, saw a small decrease in its holdings [2] - A total of 340 public funds did not disclose their holdings this quarter, including various funds such as the招商量化精选股票发起式A and the博时医疗保健混合A [2] - In the insurance capital sector, one insurance company, 瑞众人寿保险有限责任公司-自有资金, reduced its holdings slightly compared to the previous quarter [2]

Group 1 - The company announced the suspension of subscription services for the Yinhua CSI Infrastructure ETF Fund starting from May 26, 2025, while redemption and conversion services will continue to operate normally [1] - The company has signed a sales agency agreement with Western Securities to add it as a broker for several ETFs, effective May 26, 2025 [2] - The company has also signed a sales agency agreement with Dongwu Securities to include it as a broker for the Yinhua CSI Mainland Low-Carbon Economy ETF, effective May 26, 2025 [3]

Core Viewpoint - The company, Yinhua Fund Management Co., Ltd., announces a fee discount activity for its Yinhua Zhongzhai 1-3 Year Agricultural Development Bank Bond Index Securities Investment Fund starting from May 26, 2025, to meet investor demand [1]. Group 1: Fee Discount Activity - From May 26, 2025, investors can purchase the fund through participating distribution agencies with fee discounts based on specific arrangements by the agencies, while fixed fee rates will remain unchanged [2]. - The fee discount activity is limited to the front-end model for off-site transactions, and any changes to the activity or rules will be communicated through the respective distribution agencies [2]. - The interpretation rights of the fee discount activity content belong to the participating distribution agencies, and the rules and processes for business handling will follow their arrangements [2]. Group 2: Additional Distribution Agencies - Starting from May 26, 2025, the company will add Western Securities Co., Ltd. and Dongwu Securities Co., Ltd. as distribution agents for several of its exchange-traded funds (ETFs) [9][10]. - The specific ETFs include Yinhua Guozheng Free Cash Flow ETF, Yinhua Zhongzheng A50 ETF, Yinhua Zhongzheng Film Theme ETF, Yinhua Zhongzheng Innovative Drug Industry ETF, Yinhua Zhongzheng 5G Communication Theme ETF, Yinhua Hu-Shen 300 Value ETF, Yinhua Zhongzheng 500 Value ETF, and Yinhua Zhongzheng National New Central Enterprise Technology Leading ETF [9][10].